MDxHealth Expands in the Netherlands
California-based life sciences company opens research laboratory at Novio Tech Campus
Life sciences company MDxHealth is expanding in the Netherlands with a new service and research laboratory. The California based company has opened a 7,500-square-foot lab at Novio Tech Campus in Nijmegen. Novio is a corporate health-tech park that supports emerging multinational life sciences technology companies. The park is also supported by Radboud University Medical Centre.
MDxHealth focuses on the diagnosis and treatment of cancer. From its new Dutch laboratory, the company will perform its SelectMDx for Prostate Cancer test and conduct R&D and commercial activities. Its Dutch operations also support the growth of its diagnostics business worldwide.
Life Sciences in the Netherlands
The Novio Tech Campus is part of Holland’s network of research institutes, which also includes Utrecht Science Park and Maastricht University Medical Centre. In fact, the Netherlands has 12 research universities and eight university medical centers.
More than 3,000 life sciences companies and research organizations operate in the Netherlands. Holland is also No. 1 on the Euro Health Consumer Index. Life sciences companies like MDxHealth also benefit from Holland’s pro-business climate. With its strategic location, the Netherlands is an ideal entry to the European market.
MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalise the diagnosis and treatment of cancer. The company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy.